Insulet enrolled the first participant in a study of its fully closed-loop automated insulin delivery system for type 2 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Hybrid closed-loop insulin delivery was most ...

Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

Insulet anticipates a 510(k) submission for its fully closed-loop AID system in 2027 and market launch in 2028.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Pregnant women with type 1 diabetes had a higher time in ...

Even patients with type 2 diabetes can benefit from using a fully closed-loop insulin delivery system, also known as an artificial pancreas, according to an open-label crossover trial. In the ...

The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...

Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. A ...

A new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences. The study is published in the peer-reviewed journal ...

In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...